FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313877500> ?p ?o ?g. }

• W4313877500 endingPage "36" @default.
• W4313877500 startingPage "29" @default.
• W4313877500 abstract "Aim: Despite numerous available antiemetics, chemotherapy induced nausea and vomiting (CINV) still affects many patients, and CINV related hospitalizations and costs often result. Materials & methods: PrecisionQ analyzed its database to evaluate CINV related hospitalizations and costs following antiemetics use including netupitant/fosnetupitant with palonosetron (NEPA), aprepitant/fosaprepitant with ondansetron (APON) or aprepitant/fosaprepitant with palonosetron (APPA) in patients receiving highly emetogenic chemotherapy or moderately emetogenic chemotherapy. Results: Database analysis identified 15,583 patient records (807 NEPA, 2023 APON, 12,753 APPA) and mean CINV related hospitalization costs were lower across all patients receiving NEPA (US$301) compared with patients receiving APON ($1006, p < 0.0001) or APPA ($321, p < 0.0001). Conclusion: NEPA is associated with lower CINV related hospitalization costs compared with APON and APPA among patients receiving highly emetogenic chemotherapy or moderately emetogenic chemotherapy.Chemotherapy patients often experience nausea and vomiting that not only has a negative impact on the patient’s quality of life but can also result in unplanned hospitalizations with high associated costs. Numerous medications and specific guidelines are available to prevent nausea and vomiting in patients with cancer. Specifically, the combination of two classes of medications (serotonin inhibitors + neurokinin type 1 inhibitors) has been shown to provide the greatest benefit. However, hospitalizations due to nausea and vomiting still occur, and providers require further information to determine the best options for their patients. In this study, the combination of netupitant/fosnetupitant with palonosetron resulted in lower hospitalization costs compared with aprepitant/fosaprepitant with ondansetron or aprepitant/fosaprepitant with palonosetron in chemotherapy patients." @default.
• W4313877500 created "2023-01-10" @default.
• W4313877500 creator A5032959916 @default.
• W4313877500 creator A5034515374 @default.
• W4313877500 creator A5051720449 @default.
• W4313877500 creator A5074104005 @default.
• W4313877500 creator A5077613669 @default.
• W4313877500 creator A5078361948 @default.
• W4313877500 creator A5090101135 @default.
• W4313877500 date "2023-01-01" @default.
• W4313877500 modified "2023-10-14" @default.
• W4313877500 title "Antiemetic use and chemotherapy induced nausea and vomiting related hospitalization costs after highly or moderately emetogenic chemotherapy" @default.
• W4313877500 cites W1618014374 @default.
• W4313877500 cites W1895871141 @default.
• W4313877500 cites W2074447551 @default.
• W4313877500 cites W2087575003 @default.
• W4313877500 cites W2156319350 @default.
• W4313877500 cites W2162984217 @default.
• W4313877500 cites W2189042353 @default.
• W4313877500 cites W2527377692 @default.
• W4313877500 cites W2566652771 @default.
• W4313877500 cites W2599863736 @default.
• W4313877500 cites W2604708549 @default.
• W4313877500 cites W2741225080 @default.
• W4313877500 cites W2751763900 @default.
• W4313877500 cites W2766471730 @default.
• W4313877500 cites W2770753485 @default.
• W4313877500 cites W2897926111 @default.
• W4313877500 cites W2903337115 @default.
• W4313877500 cites W2916840282 @default.
• W4313877500 cites W2946557018 @default.
• W4313877500 cites W2948032169 @default.
• W4313877500 cites W2966456946 @default.
• W4313877500 cites W3014666605 @default.
• W4313877500 cites W3041685519 @default.
• W4313877500 cites W3111383990 @default.
• W4313877500 cites W3153717930 @default.
• W4313877500 cites W3216498462 @default.
• W4313877500 cites W4207079979 @default.
• W4313877500 cites W4214889712 @default.
• W4313877500 doi "https://doi.org/10.2217/fon-2022-0972" @default.
• W4313877500 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36622264" @default.
• W4313877500 hasPublicationYear "2023" @default.
• W4313877500 type Work @default.
• W4313877500 citedByCount "1" @default.
• W4313877500 countsByYear W43138775002023 @default.
• W4313877500 crossrefType "journal-article" @default.
• W4313877500 hasAuthorship W4313877500A5032959916 @default.
• W4313877500 hasAuthorship W4313877500A5034515374 @default.
• W4313877500 hasAuthorship W4313877500A5051720449 @default.
• W4313877500 hasAuthorship W4313877500A5074104005 @default.
• W4313877500 hasAuthorship W4313877500A5077613669 @default.
• W4313877500 hasAuthorship W4313877500A5078361948 @default.
• W4313877500 hasAuthorship W4313877500A5090101135 @default.
• W4313877500 hasBestOaLocation W43138775001 @default.
• W4313877500 hasConcept C126322002 @default.
• W4313877500 hasConcept C143998085 @default.
• W4313877500 hasConcept C2776694085 @default.
• W4313877500 hasConcept C2776712918 @default.
• W4313877500 hasConcept C2777170512 @default.
• W4313877500 hasConcept C2779924295 @default.
• W4313877500 hasConcept C2780574406 @default.
• W4313877500 hasConcept C2780580376 @default.
• W4313877500 hasConcept C2780852908 @default.
• W4313877500 hasConcept C2780884295 @default.
• W4313877500 hasConcept C42219234 @default.
• W4313877500 hasConcept C71924100 @default.
• W4313877500 hasConceptScore W4313877500C126322002 @default.
• W4313877500 hasConceptScore W4313877500C143998085 @default.
• W4313877500 hasConceptScore W4313877500C2776694085 @default.
• W4313877500 hasConceptScore W4313877500C2776712918 @default.
• W4313877500 hasConceptScore W4313877500C2777170512 @default.
• W4313877500 hasConceptScore W4313877500C2779924295 @default.
• W4313877500 hasConceptScore W4313877500C2780574406 @default.
• W4313877500 hasConceptScore W4313877500C2780580376 @default.
• W4313877500 hasConceptScore W4313877500C2780852908 @default.
• W4313877500 hasConceptScore W4313877500C2780884295 @default.
• W4313877500 hasConceptScore W4313877500C42219234 @default.
• W4313877500 hasConceptScore W4313877500C71924100 @default.
• W4313877500 hasFunder F4320332631 @default.
• W4313877500 hasIssue "1" @default.
• W4313877500 hasLocation W43138775001 @default.
• W4313877500 hasLocation W43138775002 @default.
• W4313877500 hasOpenAccess W4313877500 @default.
• W4313877500 hasPrimaryLocation W43138775001 @default.
• W4313877500 hasRelatedWork W100286279 @default.
• W4313877500 hasRelatedWork W1480067006 @default.
• W4313877500 hasRelatedWork W2052445101 @default.
• W4313877500 hasRelatedWork W2099365808 @default.
• W4313877500 hasRelatedWork W2133609698 @default.
• W4313877500 hasRelatedWork W22360130 @default.
• W4313877500 hasRelatedWork W2429814034 @default.
• W4313877500 hasRelatedWork W2806893525 @default.
• W4313877500 hasRelatedWork W2953429140 @default.
• W4313877500 hasRelatedWork W4245250147 @default.
• W4313877500 hasVolume "19" @default.
• W4313877500 isParatext "false" @default.
• W4313877500 isRetracted "false" @default.

• next